Llwytho...
Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion
AIM: Pretreatment with mineralocorticoid receptor (MR) antagonists is reported to reduce myocardial infarct size from ischemia/reperfusion. Here, we tested whether the MR antagonists potassium canrenoate and eplerenone could protect in the more clinically relevant schedule of administration at the e...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2010
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3063847/ https://ncbi.nlm.nih.gov/pubmed/20028693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehp555 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|